Teva Pharmaceutical Industries Limited (NYSE: TEVA): One Stock To Trade As Economic Progress Advances – Marketing Sentinel
Home  »  Company   »  Teva Pharmaceutical Industries Limited (NYSE: TEVA...

Teva Pharmaceutical Industries Limited (NYSE: TEVA): One Stock To Trade As Economic Progress Advances

In today’s recent session, 5.29 million shares of the Teva Pharmaceutical Industries Limited (NYSE:TEVA) have been traded, and its beta is 1.31. Most recently the company’s share price was $9.91, and it changed around $0.08 or 0.86% from the last close, which brings the market valuation of the company to $10.85B. TEVA at last check was trading at a discount to its 52-week high of $10.50, offering almost -5.95% off that amount. The share price’s 52-week low was $6.78, which indicates that the recent value has risen by an impressive 31.58% since then. We note from Teva Pharmaceutical Industries Limited’s average daily trading volume that its 10-day average is 22.54 million shares, with the 3-month average coming to 12.68 million.

Teva Pharmaceutical Industries Limited stock received a consensus recommendation rating of a Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 1 out of 14 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 12 recommended TEVA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Teva Pharmaceutical Industries Limited is expected to report earnings per share of $0 for the current quarter.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Teva Pharmaceutical Industries Limited (NYSE:TEVA) trade information

Instantly TEVA has been showing a green trend so far today with a performance of 0.86% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 9.95 on Tuesday, 08/02/22 increased the stock’s daily price by 0.4%. The company’s shares are currently up 22.72% year-to-date, but still up 38.06% over the last five days. On the other hand, Teva Pharmaceutical Industries Limited (NYSE:TEVA) is 24.59% up in the 30-day period. We can see from the shorts that 17.76 million shares have been sold at a short interest cover period of 1.42 day(s).

The consensus price target as assigned by Wall Street analysts is $10.22, which translates to bulls needing to increase their stock price by 3.03% from its current value. Analyst projections state that TEVA is forecast to be at a low of $8.00 and a high of $13.00. In order for the stock price to hit the forecast high, the stock would need to plunge -31.18% from its current level, while the stock would need to crash 19.27% from its current level to reach the projected low.

Teva Pharmaceutical Industries Limited (TEVA) estimates and forecasts

Teva Pharmaceutical Industries Limited share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 16.61 percent over the past six months and at a -2.33% annual growth rate that is well below the industry average of 0.20%. The year-over-year growth rate is expected to be -1.30%, down from the previous year.

Consensus estimates provided by 9 financial analysts predict the company will bring in an average of $3.78 billion in revenue for the current quarter. 9 analysts expect Teva Pharmaceutical Industries Limited to make $3.97 billion in revenue for the quarter ending Sep 2022. Analysts predict that the company’s current quarter sales will drop, forecast at -6.40%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 39.70%. Teva Pharmaceutical Industries Limited earnings are expected to increase by 110.30% in 2022, but the outlook is positive 2.00% per year for the next five years.

TEVA Dividends

Teva Pharmaceutical Industries Limited’s next quarterly earnings report is expected to be released in September.

Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 1.50% of Teva Pharmaceutical Industries Limited shares, and 46.25% of them are in the hands of institutional investors. The stock currently has a share float of 46.96%. Teva Pharmaceutical Industries Limited stock is held by 607 institutions, with Capital Research Global Investors being the largest institutional investor. By Mar 30, 2022, it held 11.90% of the shares, which is about 132.17 million shares worth $1.24 billion.

Blackrock Inc., with 3.75% or 41.65 million shares worth $391.08 million as of Mar 30, 2022, holds the second largest percentage of outstanding shares.

Investment Company Of America and Growth Fund Of America Inc were the top two Mutual Funds as of Jun 29, 2022. The former held 71.72 million shares worth $539.31 million, making up 6.46% of all outstanding shares. On the other hand, Growth Fund Of America Inc held roughly 20.0 million shares worth around $150.39 million, which represents about 1.80% of the total shares outstanding.

Leave a Comment

Your email address will not be published.

On Key

Related Posts